Celgene Patient Assistance Program (PAP)ABRAXANE may be available at no cost for qualified patients who are uninsured or underinsured. Independent third-party organizations
Full Answer
See more
What is Celgene's special care?
At Celgene, we take special care to provide patients safe access to our treatments. We have developed unique, industry-leading programs under which hundreds of thousands of patients worldwide have accessed the clinical benefits of our therapies.
What is Celgene's mission?
Across Europe, Celgene provides support to organizations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact.
What is Celgene's major investment?
Celgene invests significant resources into the research and development of disease altering therapies for cancer and other serious immune-inflammatory conditions.
Is Celgene a member of the European Federation of Pharmaceutical Industries and Associations?
Celgene is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) and is compliant with Principles for Responsible Clinical Trial Data Sharing and is compliant with regulatory requirements for registration and results posting.
Eligibility
Innohep Patient Assistance Program, a patient assistance program provided by Pharmion Corporation, offers a month long supply of Innohep at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Celgene Corporation program directly.
What percentage of patients have grade 3 neutropenia?from abraxanepro.com
In clinical studies, Grade 3-4 neutropenia occurred in 34% of patients with metastatic breast cancer (MBC), 47% of patients with non–small cell lung cancer (NSCLC), and 38% of patients with pancreatic cancer.
What is the number to call for Abraxane?from bms.com
For more information about how insurance covers ABRAXANE and co-pay assistance for eligible, commercially-insured patients, visit Bristol Myers Squibb Access Support or call 1-800-861-0048. Assistance for Uninsured Patients.
Can paclitaxel cause hepatic impairment?from abraxanepro.com
The exposure and toxicity of paclitaxel can be increased in patients with hepatic impairment. Closely monitor patients with hepatic impairment for severe myelosuppression
Is Abraxanepro for US healthcare professionals?from abraxanepro.com
The information contained in this section of www.abraxanepro.com is technical in nature and is intended for US healthcare professionals only.
Is Bristol Myers Squibb merged with Celgene?from bms.com
As of 2019, Bristol Myers Squibb and Celgene have merged. If you or someone you know have possibly experienced a side effect or have a product complaint while taking a legacy Celgene product, please contact us. 1-800-640-7854. (toll free U.S. only) Bristol Myers Squibb COVID-19 Response Line. 1-800-721-8909.
Summary
Thank you for checking into Celgene Corporation patient assistance program. As of January 24th, 2012 we do not have any specific information related to Celgene Corporation's program. Please check back regularly as we are updating our database of information daily.
Eligibility
Most programs have income, age, and other eligibility requirements. At this current time we don´t have the eligibility information for Celgene Corporation's program.
Other Tips
If you have any questions please call the Celgene Corporation program directly.
What is Celgene's mission?from celgene.com
Celgene realizes its mission of improving the lives of patients around the world through our pioneering patient access programs, significant investment in clinical studies, support for continuing medical education and partnerships with charities that share our commitment to patients.#N#Learn More
What is Celgene's major investment?from celgene.com
Celgene invests significant resources into the research and development of disease altering therapies for cancer and other serious immune-inflammatory conditions.
What is the REMS program?from celgeneriskmanagement.com
The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and comply with all of the requirements for each program.
Is Celgene a member of the European Federation of Pharmaceutical Industries and Associations?from celgene.com
Celgene is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) and is compliant with Principles for Responsible Clinical Trial Data Sharing and is compliant with regulatory requirements for registration and results posting.
What percentage of patients have grade 3 neutropenia?
In clinical studies, Grade 3-4 neutropenia occurred in 34% of patients with metastatic breast cancer (MBC), 47% of patients with non–small cell lung cancer (NSCLC), and 38% of patients with pancreatic cancer.
Is Abraxanepro for US healthcare professionals?
The information contained in this section of www.abraxanepro.com is technical in nature and is intended for US healthcare professionals only.
Can paclitaxel cause hepatic impairment?
The exposure and toxicity of paclitaxel can be increased in patients with hepatic impairment. Closely monitor patients with hepatic impairment for severe myelosuppression
